After years of delays and political wrangling, the federal government’s long-awaited hearing on whether to move marijuana from Schedule I to Schedule III of the Controlled Substances Act is finally underway.
CMS Medicare GLP-1 Bridge launches July 1, expanding access to weight-loss drugs for eligible patients while adding new provider, pharmacy, billing, and compliance requirements.
New AD/CVD petitions target choline salt imports from China. Learn key dates, potential duties, and what importers and supply chain companies should do now.
The Clark Hill approach is equally pragmatic and growth-minded, which is why we understand our clients’ toughest business challenges. Our multidisciplinary, global team of advisors focuses on smart legal solutions, delivered simply.
© 2026 Clark Hill PLC.
